← Evidence map

ArticleGenome medicine2019

Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma.

Marc Ladanyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

39 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30914057